Search Results | OpenEmory

Start Over Keyword cancer phase I clinical trial

Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information

Authors:Yuzi Zhang, Emory UniversityMichael Kutner, Emory UniversityZhengjia Chen, Emory University

Date:2021

Publisher:WILEY

Publication Version:Author Accepted Manuscript (After Peer Review)
Interactive Software “Isotonic Design using Normalized Equivalent Toxicity Score (ID-NETS©TM)” for Cancer Phase I Clinical Trials

Authors:Zhengjia Chen, Emory UniversityZhibo Wang, Emory UniversityHaibin Wang, Cedars-Sinai Medical CenterTaofeek K Owonikoko, Emory UniversityJeanne Kowalski, Emory UniversityFadlo Khuri, Emory University

Date:2013

Publisher:Bentham Open

Publication Version:Final Published Version

License:Creative Commons Attribution-Noncommercial 3.0 Unported